Efficacy and Microfilaricidal Kinetics of Imatinib for the Treatment of Loa Loa

NCT02644525 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

20

Enrollment

NIH

Sponsor class

Stopped Planned interim analysis demonstrated futility of intervention

Conditions

Loiasis

Interventions

DRUG: Imatinib Mesylate
DRUG: Imatinib Mesylate
DRUG: Imatinib Mesylate
DRUG: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)